Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
it will never go below $5, perhaps a touch to $4.80. news will be out on Monday or Tuesday...
Sadly this ends up right back at
1.00. Retail is crushed.
Seems like it… for now
The shorts make money.This company is worthless,scam....
$TTOO - 25,000 shares just got picked up at $6.83 - selling for a loss ?!?
Ok, Short Bus...
I own 7 shares.
cover your short position boy!
Charting a dead company with a POS CEO doesn't make any sense. Anybody that bought after he moved the ER up to release horrible numbers and do a RS needs to have their head examined, even flippers...
It will only be a viable flip after it's under $1 again.
Hopefully it heads to the OTC soon, since there's no bloody way it will be compliant in November... He could do a RS every day, he ain't getting that $35M market cap... EVER.
Why are you using the standard Stocktwits line?
Everybody Bearish against the CEO is a short?
Are you in Junior High like the majority of posters over there?
alright good luck. Chart has a super nice set up. too many huge gaps to the top! Holding bigly and adding on dips! sooner or later should move up and start halting up.
just my opinion of course!
chart looks amazing! don't care what anyone says!
nope, down more, only watching from the sidelines.
It might be only some scam.What company would join forces with this Scam.Definitely not a real company.
$TTOO - cover that short position baby! Buyout offer coming?!?
Is the market cap above $35 Million?
I'll wait.
Do you seriously believe anything that POS con artist CEO says anymore?
Seems to have stabilized! Chart looks very bullish and has a nice set up!
This came from the 8K yesterday! I appreciate your input though!
They aren't compliant. They are far under the required market cap of $35M.
$TTOO - The T2 Biosystems team achieved a number of important milestones during the third quarter of 2023, which we believe have better positioned the company for near and long-term success. We received FDA 510(k) clearance for the T2Biothreat Panel; we received FDA Breakthrough Device designation for the Candida auris test; we filed the FDA 510(k) submission for the expanded T2Bacteria Panel; we converted 20% of our debt to equity; we raised additional capital; and we regained compliance with Nasdaq market value of listed securities requirement.
Con Clown 🤡 ®
$TTOO - doubled my position today!
Lmao scammer. Can’t begrudge those profit-taking on TTOO. Better than low-lives making 25 cents to rant against OTC stocks and probably dislike gains.
Thing is: Timing on the OTC is everything. Always.
Nice morning run. Looks like a 3rd day closer to compliance.
$TTOO A market cap of $1 billion could easily drive us to $300 per share. This company definitely has that kind of potential; all it needs is some major product news. 🚀💰
true that marked
These BB’s aren’t worth holding more than required. They dilute and scam retail out of their money!
It’s best to just play the wave!
Nasdaq has become a nest for the OTC scams .Wall street can become a second rate exchange in 10 years.China and India will take over as there are not so much corruption,naked shorting in india and China.
Cha cha.TTOO is a scam,one big scam..The company is worthless,all will lose !!
$TTOO - added again! Good luck
Last time I listened to the MF on these boards pumping stock with buyout claims. I lost most of my investment when the company filed bankruptcy. Its scumbags like you DEFRAUDING people with made up false info to lead people into losing money in buying worthless stocks believing in hopian to a big win is right around the corner like you are falsely spousing.
STFU IDIOT.
Just a copy paste con dude bs
you are spreading BS. Con man.
Maybe at $1.00
#TTOO 🔥 any chance of reversal? $TTOO
Yep. Makes no sense.
hopped back out, but will watch
TTOO: The Orion's Boys were on this one in the early, early, early, PRE-Mkt., since it was no longer a Stinky Pinky. I didn't grab any of it. Nevertheless, RS's have been 'trending' of late.
TTOO: Although I've traded for years now, I normally NEVER check to see what ANY stock's price was BEFORE a Reverse Split. However, since RS's have recently become 'vogue' & 'trending', I just today checked TTOO's price HISTORY and was cluelessly-confused about it. YES, stupid ME for sure, but such RETROACTIVE-pricing is NEVER done in any other area of Human Commerce nor Industry, Dude. Imagine if such were done in the REAL ESTATE Industry, for example!!!! E.G., since the average price of a HOME in L.A. County today is circa $1.1-Million bucks, well then, RETROACTIVELY make such the average prices in the 1920's, 1950's, and 1990's TOO!!!!!
Yeah, it's stupid but I don't think it has anything to do with the markets, just Yahoo and MarketWatch and sites like that.
Followers
|
168
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5811
|
Created
|
12/17/14
|
Type
|
Free
|
Moderators |
This section maintained by INV4 Saving lives and improving healthcare by empowering clinicians to effectively treat patients faster At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster. We come to work every day to solve critical needs in healthcare diagnostics with innovative solutions built on our game-changing T2 Magnetic Resonance (T2MR®) detection technology. Sepsis claims more lives annually than breast cancer, prostate cancer, and AIDS combined. We’re focused on eradicating deaths due to sepsis by developing tools that help identify the most common and deadly sepsis-causing pathogens faster than ever before. Speed is critical in sepsis management. The faster patients receive effective treatment, the more likely they are to survive and have better outcomes. Better yet, early targeted therapy for bloodstream infections may prevent the progression to sepsis altogether. Our blood tests provide actionable results in just 3 to 5 hours. The only other way to identify the species-specific diagnosis requires a blood culture, which can take 1 to 5 days or more. Today, T2 Biosystems panels are getting patients on the right therapy faster, and the expedited identification of negative test results allows rapid de-escalation of unneeded therapy. In partnership with hospitals around the world, T2 Biosystems technology is uniquely positioned to strike a huge blow to sepsis and the hundreds of thousands of lives it takes each year. Our T2Bacteria® and T2Candida® Panels run on the automated T2Dx® Instrument. They are the first and only FDA-cleared blood tests that identify sepsis-causing pathogens without the wait for blood culture. As hospitals continue to adopt our technology, it will represent a paradigm shift that can potentially result in thousands of patients going home to their families instead of the tragic, and potentially avoidable, alternative. We have an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens About our name: T2 refers to the measurement of the reaction of water molecules in the presence of magnetic fields. This is what our T2MR technology measures, and it is the inspiration behind our company’s name. T2Dx Instrument Breakthrough technology enabling direct detection from whole blood The FDA-cleared T2Dx® Instrument is a fully automated, walk away, clinical multiplex benchtop diagnostic system capable of running tests directly from whole blood. The benefits of the T2Dx Instrument include
The T2Dx Instrument serves nearly 200 hospitals worldwide and is powered by T2 Magnetic Resonance (T2MR®) technology. ================================== Innovative T2MR®applications currently in development T2 Biosystems has multiple diagnostic applications in development, all designed to enable further breakthroughs in rapid and accurate therapy for patients. The diagnostics are focused on critical, unmet needs in healthcare, where solutions can serve a dual role of improving patient care while reducing costs. T2Resistance® Panel: T2 Biosystems has partnered with Allergan and CARB-X to develop panels with additional bacterial species and resistance markers. The T2Resistance Panel detects gram-negative and gram-positive resistance markers and is currently available for research use only (RUO) in the U.S. and CE marked on November 20, 2019. T2Cauris™ Panel RUO: Direct detection of the emerging superbug Candida auris in patient skin and blood samples and hospital environmental samples are now available for research use only (RUO) assays. The CDC* validated the T2Cauris Panel RUO swab test on patient skin samples and published their 2017 findings in Mycoses. 1. ANSON FUNDS MANAGEMENT LP Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise investment discretion, over the assets of others, in excess of $100 Million. Major institutions include financial holdings companies, banks, insurance companies, mutual fund managers, portfolio managers, self managed pension and endowment funds. The report is limited to equity securities, including common and equivalents, convertible preferred and convertible bonds. The report does not include fixed income, real estate, or cash equivalents. Reports are filed within 45 days after calendar quarter end with the vast majority of updates occurring near the 45th day of the quarter. About Institutional Holdings Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. https://www.nasdaq.com/market-activity/stocks/ttoo/institutional-holdings Contact 101 Hartwell Avenue |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |